DEBRUMAB 60MG INJECTION

About DEBRUMAB 60MG INJECTION

Debrumab 60MG Injection contains denosumab 60mg. It slows the cells that break down bone, which helps keep bones strong, which is why it is classed as an RANKL-blocking monoclonal antibody (bone-targeted therapy). Specialists use it for osteoporosis in women after menopause and in men, and bone loss from hormone therapy for prostate or breast cancer. During treatment expect regular checks such as calcium and vitamin D levels and a dental check before starting. Made by RPG Life Sciences; pack size 1 PFS. MRP Rs 5,941 as per the NPPA revision of 9 November 2026. Never start, stop or change it on your own - the oncologist or specialist decides the plan.